FDA Official: Agency’s Guidance Process Will Slow Down After Pandemic

By Beth Wang / July 21, 2021 at 3:28 PM
Throughout the COVID-19 pandemic, FDA has worked at an around-the-clock pace to publish guidance quickly and frequently, but regulated industries should not expect the agency to maintain that pace once the pandemic is over, an FDA official told stakeholders Tuesday (July 20). The speed with which FDA has been working is unsustainable, the official added. “We always strive to put out our policy as quickly as possible, but the pace by which we are operating right now is just not...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.